Cargando…

Centenarian Exomes as a Tool for Evaluating the Clinical Relevance of Germline Tumor Suppressor Mutations

OBJECTIVES: The aim of the present study was to evaluate the clinical relevance of mutations in tumor suppressor genes using whole-exome sequencing data from centenarians and young healthy individuals. METHODS: Two pools, one of centenarians and one of young individuals, were constructed and whole-e...

Descripción completa

Detalles Bibliográficos
Autores principales: Balabanski, Lubomir, Serbezov, Dimitar, Nikolova, Dragomira, Antonova, Olga, Nesheva, Desislava, Hammoudeh, Zora, Vazharova, Radoslava, Karachanak-Yankova, Sena, Staneva, Rada, Mihaylova, Marta, Damyanova, Vera, Hadjidekova, Savina, Toncheva, Draga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132786/
https://www.ncbi.nlm.nih.gov/pubmed/32233832
http://dx.doi.org/10.1177/1533033820911082
_version_ 1783517505266909184
author Balabanski, Lubomir
Serbezov, Dimitar
Nikolova, Dragomira
Antonova, Olga
Nesheva, Desislava
Hammoudeh, Zora
Vazharova, Radoslava
Karachanak-Yankova, Sena
Staneva, Rada
Mihaylova, Marta
Damyanova, Vera
Hadjidekova, Savina
Toncheva, Draga
author_facet Balabanski, Lubomir
Serbezov, Dimitar
Nikolova, Dragomira
Antonova, Olga
Nesheva, Desislava
Hammoudeh, Zora
Vazharova, Radoslava
Karachanak-Yankova, Sena
Staneva, Rada
Mihaylova, Marta
Damyanova, Vera
Hadjidekova, Savina
Toncheva, Draga
author_sort Balabanski, Lubomir
collection PubMed
description OBJECTIVES: The aim of the present study was to evaluate the clinical relevance of mutations in tumor suppressor genes using whole-exome sequencing data from centenarians and young healthy individuals. METHODS: Two pools, one of centenarians and one of young individuals, were constructed and whole-exome sequencing was performed. We examined the whole-exome sequencing data of Bulgarian individuals for carriership of tumor suppressor gene variants. RESULTS: Of all variants annotated in both pools, 5080 (0.06%) are variants in tumor suppressor genes but only 46 show significant difference in allele frequencies between the two studied groups. Four variants (0.004%) are pathogenic/risk factors according to single nucleotide polymorphism database: rs1566734 in PTPRJ, rs861539 in XRCC3, rs203462 in AKAP10, and rs486907 in RNASEL. DISCUSSION: Based on their high minor allele frequencies and presence in the centenarian group, we could reclassify them from pathogenic/risk factors to benign. Our study shows that centenarian exomes can be used for re-evaluating the clinically uncertain variants.
format Online
Article
Text
id pubmed-7132786
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-71327862020-04-13 Centenarian Exomes as a Tool for Evaluating the Clinical Relevance of Germline Tumor Suppressor Mutations Balabanski, Lubomir Serbezov, Dimitar Nikolova, Dragomira Antonova, Olga Nesheva, Desislava Hammoudeh, Zora Vazharova, Radoslava Karachanak-Yankova, Sena Staneva, Rada Mihaylova, Marta Damyanova, Vera Hadjidekova, Savina Toncheva, Draga Technol Cancer Res Treat Original Article OBJECTIVES: The aim of the present study was to evaluate the clinical relevance of mutations in tumor suppressor genes using whole-exome sequencing data from centenarians and young healthy individuals. METHODS: Two pools, one of centenarians and one of young individuals, were constructed and whole-exome sequencing was performed. We examined the whole-exome sequencing data of Bulgarian individuals for carriership of tumor suppressor gene variants. RESULTS: Of all variants annotated in both pools, 5080 (0.06%) are variants in tumor suppressor genes but only 46 show significant difference in allele frequencies between the two studied groups. Four variants (0.004%) are pathogenic/risk factors according to single nucleotide polymorphism database: rs1566734 in PTPRJ, rs861539 in XRCC3, rs203462 in AKAP10, and rs486907 in RNASEL. DISCUSSION: Based on their high minor allele frequencies and presence in the centenarian group, we could reclassify them from pathogenic/risk factors to benign. Our study shows that centenarian exomes can be used for re-evaluating the clinically uncertain variants. SAGE Publications 2020-04-01 /pmc/articles/PMC7132786/ /pubmed/32233832 http://dx.doi.org/10.1177/1533033820911082 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Balabanski, Lubomir
Serbezov, Dimitar
Nikolova, Dragomira
Antonova, Olga
Nesheva, Desislava
Hammoudeh, Zora
Vazharova, Radoslava
Karachanak-Yankova, Sena
Staneva, Rada
Mihaylova, Marta
Damyanova, Vera
Hadjidekova, Savina
Toncheva, Draga
Centenarian Exomes as a Tool for Evaluating the Clinical Relevance of Germline Tumor Suppressor Mutations
title Centenarian Exomes as a Tool for Evaluating the Clinical Relevance of Germline Tumor Suppressor Mutations
title_full Centenarian Exomes as a Tool for Evaluating the Clinical Relevance of Germline Tumor Suppressor Mutations
title_fullStr Centenarian Exomes as a Tool for Evaluating the Clinical Relevance of Germline Tumor Suppressor Mutations
title_full_unstemmed Centenarian Exomes as a Tool for Evaluating the Clinical Relevance of Germline Tumor Suppressor Mutations
title_short Centenarian Exomes as a Tool for Evaluating the Clinical Relevance of Germline Tumor Suppressor Mutations
title_sort centenarian exomes as a tool for evaluating the clinical relevance of germline tumor suppressor mutations
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132786/
https://www.ncbi.nlm.nih.gov/pubmed/32233832
http://dx.doi.org/10.1177/1533033820911082
work_keys_str_mv AT balabanskilubomir centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations
AT serbezovdimitar centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations
AT nikolovadragomira centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations
AT antonovaolga centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations
AT neshevadesislava centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations
AT hammoudehzora centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations
AT vazharovaradoslava centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations
AT karachanakyankovasena centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations
AT stanevarada centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations
AT mihaylovamarta centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations
AT damyanovavera centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations
AT hadjidekovasavina centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations
AT tonchevadraga centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations